Here, we focused on evaluating the possible association of HLA-G 3’UTR polymorphisms with sHLA-G plasma levels in the Chinese Han population and its value in clinical prognostic evaluation and survival outcome prediction in patients with cervical cancer. The gene discussed is HLA-G; the disease is cervical carcinoma.